Synthesis and structure–activity relationships and effects of phenylpropanoid amides of octopamine and dopamine on tyrosinase inhibition and antioxidation
摘要:
Phenylpropanoid amides of octopamine (OA) 1a-1e and dopamine (DA) 2a-2e were synthesised and the structure-activity relationships (SARs) for antioxidant and tyrosinase inhibition activities were analysed. Among synthesised compounds, 2c, which contains two catechol moieties, exhibited the most DPPH radical-scavenging activity (EC50 = 16.2 +/- 2.41 mu M), and id exhibited significant tyrosinase inhibitory activity (IC50 = 5.3 +/- 1.8 mu M). Interestingly, with the same acid moiety, OA derivatives showed more inhibitory effect on tyrosinase than did compounds derived from DA, whereas DA derivatives were found to have higher antioxidant activity than compounds derived from OA. The relationship between their structures and their potencies, demonstrated in the current study, will be useful for the design of optimal agents. (C) 2012 Elsevier Ltd. All rights reserved.
Abstract In elicitor-treated photomixotrophic Solanumkhasianumcellcultures, nine phenolic compounds accumulated in the cellculture medium. They were isolated and structurally identified as the cis - and trans -isomers of N - p -coumaroyloctopamine, N -feruloyloctopamine, N - p -coumaroyltyramine and N -feruloyltyramine as well as α-hydroxyacetovanillone. The cis -isomers of the hydroxycinnamoyl moieties
[EN] METHODS FOR REVERSING HEPATIC STEATOSIS<br/>[FR] PROCÉDÉS D'INVERSION DE LA STÉATOSE HÉPATIQUE
申请人:[en]BRIGHTSEED, INC.
公开号:WO2022081567A1
公开(公告)日:2022-04-21
Disclosed herein are methods for reversing hepatic steatosis by providing a consumable composition. Some embodiments provided include, for example, administering a compound of Formula (I) or compound of Formula (II). Some embodiments provide the composition is formulated as a dietary supplement, food ingredient or additive, a medical food, nutraceutical or pharmaceutical composition.